Novo Nordisk
NVO
#33
Rank
NZ$510.75 B
Marketcap
$116.32
Share price
-1.12%
Change (1 day)
-45.09%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2024 (TTM): NZ$31.55 Billion

According to Novo Nordisk's latest financial reports the company's current earnings are NZ$41.89 Billion. , an increase over its 2023 earnings that were of NZ$26.59 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2024

Annual earnings

Year Earnings Change
2024 NZ$32.65 B22.75%
2023 NZ$26.59 B57.64%
2022 NZ$16.87 B5.35%
2021 NZ$16.01 B12.47%
2020 NZ$14.24 B13.07%
2019 NZ$12.59 B-3.35%
2018 NZ$13.03 B1.79%
2017 NZ$12.80 B4.52%
2016 NZ$12.24 B9.42%
2015 NZ$11.19 B8.24%
2014 NZ$10.34 B3.45%
2013 NZ$9.99 B19.02%
2012 NZ$8.39 B15.21%
2011 NZ$7.29 B17.71%
2010 NZ$6.19 B24.78%
2009 NZ$4.96 B10.62%
2008 NZ$4.48 B55.97%
2007 NZ$2.87 B7.07%
2006 NZ$2.68 B18.18%
2005 NZ$2.27 B11.33%
2004 NZ$2.04 B
2002 NZ$1.31 B-14.39%
2001 NZ$1.53 B-52.82%
2000 NZ$3.24 B250%
1999 NZ$0.92 B31.21%
1998 NZ$0.70 B34.31%
1997 NZ$0.52 B11.46%
1996 NZ$0.47 B9.03%
1995 NZ$0.43 B-3.15%
1994 NZ$0.44 B-0.67%
1993 NZ$0.45 B45.38%
1992 NZ$0.30 B-13.81%
1991 NZ$0.35 B37.12%
1990 NZ$0.26 B-0.79%
1989 NZ$0.26 B26.2%
1988 NZ$0.20 B24.97%
1987 NZ$0.16 B-0.9%
1986 NZ$0.16 B-7.78%
1985 NZ$0.18 B24.87%
1984 NZ$0.14 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NZ$19.15 B-41.33%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$21.85 B-33.05%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$14.45 Billion-144.24%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$13.69 B-58.07%๐Ÿ‡ซ๐Ÿ‡ท France